Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
Clinical trial NCT04906473 · UNKNOWN
Trial details
- NCT number
- NCT04906473
- Sponsor
- Kunming Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-31
- Primary completion
- 2022-12-31
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.